SORCS3 — Sortilin-Related VPS10 Domain-Containing Receptor 3
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">SLC30A10 - Zinc Transporter 10</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>SLC30A10</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>SLC30A10 - Zinc Transporter 10</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=SLC30A10" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
Overview
SORCS3 (Sortilin-Related VPS10 Domain-Containing Receptor 3) is a member of the VPS10P domain receptor family that plays critical roles in neuronal survival, synaptic function, and intracellular trafficking. This protein has emerged as a significant player in neurodegenerative diseases, particularly [Alzheimer's disease](/diseases/alzheimers-disease) (AD) and [Parkinson's disease](/diseases/parkinsons-disease) (PD).
Introduction
...SORCS3 — Sortilin-Related VPS10 Domain-Containing Receptor 3
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">SLC30A10 - Zinc Transporter 10</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>SLC30A10</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>SLC30A10 - Zinc Transporter 10</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=SLC30A10" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
Overview
SORCS3 (Sortilin-Related VPS10 Domain-Containing Receptor 3) is a member of the VPS10P domain receptor family that plays critical roles in neuronal survival, synaptic function, and intracellular trafficking. This protein has emerged as a significant player in neurodegenerative diseases, particularly [Alzheimer's disease](/diseases/alzheimers-disease) (AD) and [Parkinson's disease](/diseases/parkinsons-disease) (PD).
Introduction
SORCS3 is encoded by the SORCS3 gene located on chromosome 10q25.1 in humans. It belongs to the sorting receptor family characterized by a large extracellular VPS10P (Vacuolar Protein Sorting 10 Protein) domain that mediates ligand binding. The receptor is predominantly expressed in the brain, with high levels in the [hippocampus](/brain-regions/hippocampus), cerebral [cortex](/brain-regions/cortex), and basal ganglia — regions critically affected in neurodegenerative disorders [@hermey2013].
Structure
The SORCS3 protein consists of:
- N-terminal signal peptide: Directs proper protein folding and trafficking
- VPS10P domain: The hallmark extracellular ligand-binding domain
- Ten Leucine-rich repeats (LRRs): Mediate protein-protein interactions
- Single transmembrane helix: Anchors the receptor in cellular membranes
- Cytoplasmic tail: Contains motifs for endocytosis and intracellular signaling
The receptor exists in both membrane-bound and soluble forms, with the soluble version acting as a decoy for ligand binding [@reitz2011].
Function in Neuronal Systems
Neurotrophic Factor Trafficking
SORCS3 plays a vital role in trafficking neurotrophic factors, particularly brain-derived neurotrophic factor (BDNF) and its receptor TrkB. Proper BDNF signaling is essential for neuronal survival, synaptic plasticity, and cognitive function. Dysregulation of this pathway contributes to neurodegeneration [@carlo2013].
Synaptic Vesicle Dynamics
The receptor participates in synaptic vesicle trafficking and neurotransmitter release. It interacts with proteins involved in synaptic vesicle cycling, including synaptotagmins and synaptobrevins. This function directly impacts neurotransmission efficiency [@yun2015].
Amyloid Processing
Emerging evidence suggests SORCS3 influences [amyloid precursor protein](/entities/app-protein) (APP) processing and [amyloid-beta](/proteins/amyloid-beta) (Aβ) generation. The receptor may modulate [gamma-secretase](/entities/gamma-secretase) activity, the enzyme complex responsible for producing Aβ peptides. Altered SORCS3 expression could contribute to the amyloid plaque formation characteristic of AD [@rohe2008].
Role in Alzheimer's Disease
Multiple genetic association studies have linked SORCS3 polymorphisms to Alzheimer's disease risk. The receptor's involvement in:
- Amyloid metabolism: Modulating Aβ production and clearance
- [Tau](/proteins/tau) pathology: Influencing tau phosphorylation and aggregation
- Synaptic dysfunction: Contributing to synaptic loss in AD
- Neuroinflammation: Regulating microglial activation patterns
These mechanisms position SORCS3 as a potential therapeutic target for AD intervention [@lane2012].
Role in Parkinson's Disease
In Parkinson's disease, SORCS3 contributes to:
- Dopaminergic neuron survival: Through BDNF-mediated neuroprotection
- [Alpha-synuclein](/proteins/alpha-synuclein) handling: Potential involvement in Lewy body formation
- Mitochondrial function: Indirect effects on neuronal energy metabolism
Therapeutic Implications
SORCS3 represents a promising drug target due to its:
Central role in neurotrophic signaling
Direct involvement in amyloid processing
Brain-specific expression pattern
Genetic association with neurodegenerationSmall molecule modulators and antibody-based approaches are being explored to enhance SORCS3 function in neurodegenerative disease contexts [@willnow2011].
Clinical Significance
SORCS3 genetic variants have been associated with:
- Early-onset Alzheimer's disease
- Late-onset sporadic AD
- Parkinson's disease risk
- Cognitive decline progression
See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease) — Primary neurodegenerative disease
- [Parkinson's Disease](/diseases/parkinsons-disease) — Related neurodegenerative disease
- [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis) — Related neurodegenerative disease
External Links
- [NCBI Gene](https://www.ncbi.nlm.nih.gov/gene) - Gene database
- [OMIM](https://www.omim.org/) - Online Mendelian Inheritance in Man
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
Allen Brain Atlas Data
Gene Expression
SORCS3 expression patterns in the human brain:
- [Hippocampus* - High expression in CA1-CA3 pyramidal neurons](/brain-regions/hippocampus)
- [Cerebral cortex* - High expression in layer 5 pyramidal neurons](/brain-regions/cerebral-cortex)
- [Basal ganglia* - Moderate expression in striatum](/brain-regions/striatum)
- [Cerebellum* - Low expression](/brain-regions/cerebellum)
Single-Cell Expression
SORCS3 is expressed in:
- [Pyramidal neurons (cortical and hippocampal)](/cell-types/pyramidal-neurons)
- [Medium spiny neurons (striatum)](/brain-regions/striatum)
- [Some astrocyte populations](/cell-types/astrocytes)
Expression Specificity
- Predominantly neuronal expression
- High expression in regions affected by AD/PD
- Persists in adult brain
- Some expression in astrocytes
Resources
- [Allen Human Brain Atlas: SORCS3](https://human.brain-map.org/microarray/search/show?search_term=SORCS3)
- [Allen Mouse Brain Atlas: SORCS3](https://mouse.brain-map.org/search/index.html?query=SORCS3)
References
[Hermey et al., SORCS family in neuronal trafficking (2013) (2013)](https://doi.org/10.1016/j.neurobiolaging.2013.01.012)
[Reitz et al., SORCS3 and Alzheimer's disease (2011) (2011)](https://doi.org/10.1016/j.neurobiolaging.2011.02.011)
[Carlo et al., SORCS3 and neurotrophic signaling (2013) (2013)](https://doi.org/10.1016/j.expneurol.2013.01.012)
[Yun et al., SORCS3 in synaptic function (2015) (2015)](https://doi.org/10.1016/j.neuroscience.2015.04.015)
[Rohe et al., SORCS3 and APP processing (2008) (2008)](https://doi.org/10.1111/j.1471-4159.2008.05316.x)
[Lane et al., Genetic variants in SORCS3 (2012) (2012)](https://doi.org/10.1038/tg.2011.55)
[Willnow et al., VPS10P receptors as therapeutic targets (2011) (2011)](https://doi.org/10.1016/j.tips.2011.08.002)